Results 181 to 190 of about 98,994 (359)

CKLF‐like MARVEL transmembrane domain‐containing superfamily 8 (CMTM8) promotes Notch signalling to maintain CD8+ T cell‐ and NK cell‐dependent tumour immune escape

British Journal of Pharmacology, EarlyView.
Background and Purpose The CKLF‐like MARVEL transmembrane domain containing superfamily (CMTM) has an important role in tumour immunity. The role of CMTM8 in tumour immune microenvironment (TIME) remains unknown. The aim was to investigate the relationship between CMTM8 and antitumour immunity. Experimental Approach Lentiviral system was established to
Fanglin Li, Longhua Gu, Runqiu Chen, Zhiying Li, Rong Zhang, Chen Chen, Yi Liu, Xinhang Zheng, Yiting Wang, Shanna Wu, Jianhua Sun, Jing Chen, Bingshun Wang, Likun Gong, Yiru Long   +14 more
wiley   +1 more source

RASD2 Drives Renal Clear Cell Carcinoma Progression via RAF1 (Ser338) Phosphorylation

Cancer Science, EarlyView.
RASD2 drives clear cell renal cell carcinoma (ccRCC) progression by physically interacting with RAF1 to induce its Ser338 phosphorylation, which subsequently activates the P38/ERK–MAPK signaling pathway to promote malignant tumor phenotypes and poor prognosis.
Jingxuan Yu, Gang Yu, Yuan Liu, Yu Zhou, Wei Liu, Lin Wang, Lide Liu, Yan Liu, Tiejun Pan, Zhenyu Liu, Lei Gao   +10 more
wiley   +1 more source

T-Cell Stimulation by Melanoma RNA-Pulsed Dendritic Cells

, 2004
In situations where well-established approaches such as surgery, radiation therapy and chemotherapy fail to help cancer patients, immunotherapy has the potential to be an effective alternative.
Javorovic, Miran
core  

MAPK Inhibitor‐Tolerant Persister Cells in Melanoma: Mechanisms and Therapeutic Vulnerabilities

Cancer Science, EarlyView.
Melanoma response to MAPK inhibition progresses from drug‐sensitive cells to drug‐tolerant persister states, which enable survival through adaptive signaling, metabolic rewiring, and phenotypic plasticity. These persister cells serve as an intermediate reservoir from which resistant tumors ultimately emerge. ABSTRACT Though major advancements have been
Bhoomi Shah, Mackenzie M. Mayhew, Jacob Sellers, Russell G. Witt   +3 more
wiley   +1 more source

After a Decade of Therapy Revolution in Cutaneous Melanoma-Perspectives on Emerging Treatment Strategies. [PDF]

Oncol Res
Wohlfeil SA, Utikal JS.
europepmc   +1 more source

Association between Patient’s Basic Characteristic and Clark Level in Cutaneous Malignant Melanoma

, 2017
Egie Rahmalaelani, Hermin Aminah Usman, Jono Hadi Agusni   +2 more
openalex   +2 more sources

Divergent Cellular Differentiation Pathways during the Invasive Stage of Cutaneous Malignant Melanoma Progression [PDF]

, 1999
Jon A. Reed, Bridget Finnerty, Anthony P. Albino   +2 more
openalex   +1 more source

Cutaneous Melanoma in a Rabbit With Multiple Metastatic Lesions: A Case Report. [PDF]

Case Rep Vet Med
Rostami A, Aminianfar H, Zarifian N, Samiee N, Rahmanifar A, Behniapour T.   +5 more
europepmc   +1 more source

Molecular histology on the diagnostic cutting edge between malignant melanomas and cutaneous melanocytomas (Review)

, 2009
Pierard
openalex   +2 more sources

RE: "RELIABILITY OF REPORTED SUNBURN HISTORY IN A CASE-CONTROL STUDY OF CUTANEOUS MALIGNANT MELANOMA" [PDF]

, 1998
B. H. Fox
openalex   +1 more source